A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®

NCT01096329 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoactive Sexual Desire Disorder

Interventions

DRUG: Testosterone Spray 5% and 1%
DRUG: Intrinsa® Patch and Testosterone Spray 5%
DRUG: Intrinsa® Patch and Testosterone Spray 1%

Sponsor

VIVUS LLC